Image

Global Effervescent Tablet Market – Industry Trends and Forecast to 2031

Pharmaceutical

Image

Global Effervescent Tablet Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Effervescent Tablet Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 9.78 Billion
Diagram Market Size (Forecast Year) USD 19.06 Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Effervescent Tablet Market, By Products (Medication and Supplements), Methods (Dry Methods and Wet Granulation), Type (Prescription and Over the Counter), Indication (Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, and Others), Population Type (Children and Adults), Application (Dental Products, Dietary Supplements, Pharmaceutical, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Industry Trends and Forecast to 2031.

Effervescent Tablet Market

Effervescent Tablet Market Analysis and Size

The effervescent tablet market is experiencing significant growth, driven by several key factors. One of the major drivers is the increasing consumer preference for convenient dosage forms, as effervescent tablets offer a portable and easy-to-use alternative to traditional tablets or capsules. The pleasant taste and fizzy nature of effervescent tablets make them more appealing to consumers, especially children and older adults. Another factor driving the market growth is the growing demand for dietary supplements and vitamins. Effervescent tablets are popular for delivering these nutrients due to their quick dissolving nature and high bioavailability. The rise in health consciousness and the emphasis on preventive healthcare also contribute to the increasing demand for effervescent tablets.

The global effervescent tablet market size was valued at USD 9.78 billion in 2023 and is projected to reach USD 19.06 billion by 2031, with a CAGR of 8.7% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016 - 2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Products (Medication and Supplements), Methods (Dry Methods and Wet Granulation), Type (Prescription and Over the Counter), Indication (Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, and Others), Population Type (Children and Adults), Application (Dental Products, Dietary Supplements, Pharmaceutical, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Perrigo Company plc (Ireland), Reckitt Benckiser Group PLC (U.K.), Bristol-Myers Squibb Company (U.S.), CHIESI SAS (France), Hermes Pharma (Austria), S. G. Biopharm Pvt. Ltd (India), Bliss GVS Pharma Limited (India), SCITECH (India), Alpex Solar (Switzerland), Vovantis Laboratories (India), Herbalife International of America, Inc. (U.S.), Swisse Wellness PTY LTD (Australia), Nuun (U.S.), Natur Produkt Zdrovit Sp Z O O (Poland), Vitabiotics Ltd (U.K.), Amerilab Technologies Inc. (U.S.), and HERMES ARZNEIMITTEL (Germany)

Market Opportunities

  • Increasing Urbanization
  • Expanding Geriatric Population

Market Definition

Effervescent tablets are formulated to quickly dissolve in water, releasing carbon dioxide gas. This creates a fizzy or effervescent solution, often used for medicinal purposes or as a dietary supplement. Effervescent tablets are typically used to deliver vitamins, minerals, and other active ingredients and are popular for their pleasant taste and ease of consumption.

Effervescent Tablet Market Dynamics

Drivers

  • Growing Demand for Convenient Dosage Forms

The demand for convenient dosage forms, such as effervescent tablets, is rising as consumers seek easy-to-use and portable options. Effervescent tablets offer a convenient way to consume medications and supplements, as they can be dissolved in water and consumed as a refreshing drink. This ease of use makes effervescent tablets particularly popular among busy individuals looking for convenient solutions to meet their healthcare needs. In addition, the portability of effervescent tablets makes them ideal for on-the-go consumption, enabling consumers to conveniently take their medications or supplements on-the-go without requiring water or other beverages. As a result, the market for effervescent tablets is expected to continue growing.                

  • Rising Health Consciousness

The growing focus on health and wellness drives the demand for dietary supplements and vitamins, commonly delivered in effervescent tablets. Consumers are becoming more aware of the importance of maintaining a healthy lifestyle and are actively seeking ways to improve their overall well-being. This trend is particularly pronounced among the aging population, who seek ways to maintain their health and vitality as they age. Effervescent tablets offer a convenient and effective way to deliver essential nutrients, making them popular among health-conscious consumers. In addition, the pleasant taste and fizzy nature of effervescent tablets make them more appealing to consumers, further driving their popularity in the market.

Opportunities

  • Increasing Urbanization

Urbanization is transforming lifestyles and dietary choices. As individuals migrate to urban regions, they encounter faster-paced routines and heightened stress levels, prompting a greater focus on health and well-being.Effervescent tablets offer a quick and easy way to supplement essential nutrients, making them an attractive option for urban dwellers looking to maintain their health amidst busy schedules, which is creating opportunities for market growth.    

  • Expanding Geriatric Population      

Effervescent tablets are well-suited for the elderly, as they are easy to use and digest. With age, many individuals experience difficulties in swallowing pills or capsules, making effervescent tablets a more suitable option. Furthermore, effervescent tablets can be formulated to address common health issues the elderly faces, such as bone health, joint pain, and cognitive function. As the geriatric population grows, the demand for easy-to-use and effective dosage forms such as effervescent tablets is expected to rise.

Restraints/Challenges

  • Competition from Other Dosage Forms 

Effervescent tablets offer unique benefits such as quick dissolvability and pleasant taste. Traditional dosage forms are well-established in the market and are often preferred by consumers due to familiarity and perceived effectiveness. In addition, traditional tablets and capsules may have longer shelf lives and be more cost-effective to produce, making them a more attractive option for manufacturers. Effervescent tablet manufacturers must innovate continuously to differentiate their products and convince consumers of the benefits of their unique dosage form. These tablets encounter stiff competition from traditional tablets, capsules, and other dosage forms, hindering market growth.       

  • Environmental Concerns

The packaging and production of effervescent tablets can contribute to environmental issues, which may concern environmentally conscious consumers. The production of effervescent tablets often involves using plastics and other materials that are not easily recyclable, leading to waste generation. In addition, the packaging of effervescent tablets, such as individual foil packets or tubes, can result in excess packaging waste. As consumers become more aware of environmental issues, they may seek out products with minimal environmental impact, potentially leading to a shift away from effervescent tablets, which can be a challenge for the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the effervescent tablet market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In July 2023, Bristol Myers Squibb (NYSE: BMY) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo (nivolumab) as a monotherapy for the adjuvant treatment of adults and adolescents aged 12 years and older with completely resected stage IIB or IIC melanoma. If approved, Opdivo would be the only PD-1 inhibitor indicated as an adjuvant treatment for patients within stages IIB, IIC, III, and stage IV resected melanoma, among two approvals
  • In July 2023, Bayer and the Swiss Tropical and Public Health Institute (Swiss TPH) announced a collaboration to clinically develop the compound emodepside for treating humans infected with soil-transmitted helminths. This collaboration follows the promising results of a Phase II study conducted by Swiss TPH and its partners in Tanzania. The study, published on May 18, 2023, in the New England Journal of Medicine, demonstrated the efficacy of emodepside in patients with whipworm (Trichuris trichiura) and hookworm (Ancylostoma duodenale and Necator americanus) infections

Effervescent Tablet Market Scope

The market is segmented on the basis of products, methods, type, indication, application, population type, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

  • Medication
  • Supplements

Methods

  • Dry Methods
  • Wet Granulation

Type

  • Prescription
  • Over the Counter

Indication

  • Diuretics
  • Pain Management
  • Gastric Disorders
  • Respiratory Diseases
  • Others

Population Type

  • Children
  • Adults

Application

  • Dental Products
  • Dietary Supplements
  • Pharmaceutical
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Effervescent Tablet Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, products, methods, type, indication, application, population type, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

Europe is expected to dominate the market due to rising disposable incomes. In addition, the region's development of healthcare infrastructure and increased government initiatives are expected to accelerate market growth further.

North America is expected to witness significant growth during the forecast period due to increased research and development activities and a rise in healthcare spending, which will contribute to the market's growth. Furthermore, major market players in the region will further stimulate market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The effervescent tablet market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for effervescent tablet market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the effervescent tablet market. The data is available for historic period 2011-2021.

Competitive Landscape and Effervescent Tablet Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Perrigo Company plc (Ireland)
  • Reckitt Benckiser Group PLC (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • CHIESI SAS (France)
  • Hermes Pharma (Austria)
  • S. G. Biopharm Pvt. Ltd (India)
  • Bliss GVS Pharma Limited (India)
  • Scitech (India)
  • Alpex Solar (Switzerland)
  • Vovantis Laboratories (India)
  • Herbalife International of America, Inc. (U.S.)
  •  Swisse Wellness PTY LTD (Australia)
  • Nuun (U.S.
  •  Natur Produkt Zdrovit Sp Z O O (Poland)
  • Vitabiotics Ltd (U.K.)
  • Amerilab Technologies Inc. (U.S.)
  •  HERMES ARZNEIMITTEL (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The products, methods, type, indication, application, population type, end user, distribution channel are the factors on which the effervescent tablet market research is based.
The major companies in the effervescent tablet market are Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Perrigo Company plc (Ireland), Reckitt Benckiser Group PLC (U.K.), Bristol-Myers Squibb Company (U.S.), CHIESI SAS (France), Hermes Pharma (Austria), S. G. Biopharm Pvt. Ltd (India), Bliss GVS Pharma Limited (India), SCITECH (India), Alpex Solar (Switzerland), Vovantis Laboratories (India), Herbalife International of America, Inc. (U.S.), Swisse Wellness PTY LTD (Australia), Nuun (U.S.), Natur Produkt Zdrovit Sp Z O O (Poland), Vitabiotics Ltd (U.K.), Amerilab Technologies Inc. (U.S.), and HERMES ARZNEIMITTEL (Germany).
Growing Demand for Convenient Dosage Forms and Rising Health Consciousness are the growth drivers of the effervescent tablet market.
The effervescent tablet market size will be worth USD 19.06 billion by 2031.
The effervescent tablet market growth rate will be 8.7% by 2031.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials